Replies to post #31035 on Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

If MNK delivers anywhere close to the market saturation on SeroquelXR expected there will be no fear of NAZ delisting by March.

The real elephant in the room here is there's no true intrinsic value in IPCI's generics that would cause institutional accumulation.

So unless Dr. Odidi suddenly and abruptly figures out a real path forward to unlock the science in his proprietary hyper-matrix delivery tech platform and unleashes PODRAS, Regabatin and Rexista partnerships along with the other 20 opioid based NDA's claimed to be in the pipeline IPCI will fail at ever crawling out of the rabbit hole Odidi has took us into.

This stock can easily get back to $3 per share based entirely on more generics progress over the course of the next year...but will never become what we thought it could become if Odidi continues to run the PubCo as a scientist!